Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - AP Pharma Inc. (NasdaqNM:APPA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider | Reports
Recent Events
Aug  7Earnings Announcement
Location
123 Saginaw Drive
Redwood City, CA 94063
Phone: (650) 366-2626
Fax: (650) 365-6490
Email: apos@worldnet.att.net
Employees (last reported count): 27
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 41%
·Institutional: 37% (63% of float)
(29 institutions)
·Net Inst. Selling: 70.0K shares (+0.94%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
AP Pharma Inc., formerly known as Advanced Polymer Systems, Inc., is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable and implantable delivery systems under the trade name Biochronomer. Initial targeted areas of application for the Company's technologies include pain management, inflammation, oncology, ophthalmology and orthopedic applications. The Company's product development programs are funded by royalties from topical products currently marketed by pharmaceutical partners.
More from Market Guide: Expanded Business Description

Financial Summary
AP Pharma Inc. is a leader in polymer-based delivery systems and related technologies with a broad proprietary and intellectual property platform. For the six months ended 6/30/01, total revenues rose 23% to $2 million. Net loss from continuing operations rose 21% to $2.1 million. Revenues reflect increased royalty sales of Retin-A(R)-Micro(TM) and Carac(TM). Higher loss reflects increased R&D expenses for the new bioerodible Biochronomer (TM) delivery systems.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Paul Goddard, Ph.D., 51
Chairman
--  
Michael O'Connell, 51
Pres, CEO
$400K
Gordon Sangster, 47
CFO
252K
John Barr Ph.D
VP-R&D
161K
Jayne Lange
VP-Bus. Devel.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:APPAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 12-Mar-2001
$1.625
Recent Price$1.90 
52-Week High
on 1-Nov-2000
$3.563
Beta1.72 
Daily Volume (3-month avg)23.8K
Daily Volume (10-day avg)27.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-43.4%
52-Week Change
relative to S&P500
-24.1%
Share-Related Items
Market Capitalization$38.5M
Shares Outstanding20.3M
Float12.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.94 
Earnings (ttm)-$0.20 
Earnings (mrq)-$0.06 
Sales (ttm)$0.18 
Cash (mrq)$0.99 
Valuation Ratios
Price/Book (mrq)2.01 
Price/EarningsN/A 
Price/Sales (ttm)10.30 
Income Statements
Sales (ttm)$3.74M
EBITDA (ttm)-$5.48M
Income available to common (ttm)-$4.13M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-16.69%
Return on Equity (ttm)-21.69%
Financial Strength
Current Ratio (mrq)5.46 
Debt/Equity (mrq)0 
Total Cash (mrq)$20.0M
Short Interest
As of 8-Aug-2001
Shares Short20.0K
Percent of Float0.2%
Shares Short
(Prior Month)
21.0K
Short Ratio0.74 
Daily Volume27.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.